Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP 5FU and FOLFOX for Peritoneal Malignancies
NCT00352755Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in pseudomyxoma peritonei (PMP), peritoneal carcinomatosis (PC), sponsored by Washington University School of Medicine. Started May 2006; status: terminated.
02
Drugs
fluorouracil
03
Conditions
pseudomyxoma peritonei (PMP)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT00352755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352755.